Literature DB >> 16537870

Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension.

Rosane O D Achcar1, Yoshiki Demura, Pradeep R Rai, Laima Taraseviciene-Stewart, Michael Kasper, Norbert F Voelkel, Carlyne D Cool.   

Abstract

Caveolae are cell plasma membrane microdomains implicated in organizing and concentrating many signaling molecules. In the lung, caveolae are in endothelium, smooth muscle, fibroblasts, and pneumocytes. Caveolin is the main structural protein of caveolae. Caveolin 1 is down-regulated in transformed cells and may be a tumor suppressor protein. Caveolin 2 is coexpressed and hetero-oligomerizes with caveolin 1. Because the cells of the plexiform lesions in severe pulmonary hypertension (PH) are phenotypically altered, we wondered whether these cells lack caveolin. We now demonstrate by immunolocalization that while caveolin is expressed in lung endothelial, smooth-muscle, and alveolar septal cells, its expression is absent or decreased in plexiform lesions and in some muscularized precapillary arterioles. In contrast, Western blot analysis of total lung extracts from patients with severe PH shows no significant reduction in caveolin. Similar to the human lung tissue, a rat model of severe PH demonstrates absent-to-decreased caveolin expression in the complex vascular lesions. Additionally, it appears that caveolin and heme oxygenase 1 (HO-1) [a heat shock protein] are co-expressed since HO-1 expression parallels caveolin expression in vascular lesions. We propose that loss of caveolin expression in the cells of the complex vascular lesions in severe PH reflects the proliferating and apoptosis-resistant nature of these cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537870     DOI: 10.1378/chest.129.3.696

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  44 in total

Review 1.  Pathology of pulmonary hypertension.

Authors:  Rubin M Tuder; John C Marecki; Amy Richter; Iwona Fijalkowska; Sonia Flores
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

Review 2.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

3.  The cancer paradigm of severe pulmonary arterial hypertension.

Authors:  Pradeep R Rai; Carlyne D Cool; Judy A C King; Troy Stevens; Nana Burns; Robert A Winn; Michael Kasper; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2008-06-12       Impact factor: 21.405

4.  Enhanced caveolin-1 expression in smooth muscle cells: Possible prelude to neointima formation.

Authors:  Jing Huang; John H Wolk; Michael H Gewitz; James E Loyd; James West; Eric D Austin; Rajamma Mathew
Journal:  World J Cardiol       Date:  2015-10-26

5.  Left Atrial Volume and Pulmonary Artery Diameter Are Noninvasive Measures of Age-Related Diastolic Dysfunction in Mice.

Authors:  Guillermo Medrano; Jesus Hermosillo-Rodriguez; Thuy Pham; Alejandro Granillo; Craig J Hartley; Anilkumar Reddy; Patricia Mejia Osuna; Mark L Entman; George E Taffet
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-10-28       Impact factor: 6.053

6.  Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension.

Authors:  Eric D Austin; Lijiang Ma; Charles LeDuc; Erika Berman Rosenzweig; Alain Borczuk; John A Phillips; Teresa Palomero; Pavel Sumazin; Hyunjae R Kim; Megha H Talati; James West; James E Loyd; Wendy K Chung
Journal:  Circ Cardiovasc Genet       Date:  2012-04-02

7.  Reduced expression of angiotensin I-converting enzyme in caveolin-1 knockout mouse lungs.

Authors:  Nikolaos A Maniatis; Irina V Balyasnikova; Roman Metzger; Maricela Castellon; David J Visintine; David E Schwartz; Richard D Minshall; Sergei M Danilov
Journal:  Microvasc Res       Date:  2010-04-27       Impact factor: 3.514

Review 8.  Membrane rafts and caveolae in cardiovascular signaling.

Authors:  Paul A Insel; Hemal H Patel
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

Review 9.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

Review 10.  Genomics of pulmonary arterial hypertension: implications for therapy.

Authors:  Mark W Geraci; Todd M Bull; Rubin M Tuder
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.